Long-term survival data and prognostic factors of a complete response to chemotherapy in patients with head and neck cancer treated with platinum-based induction chemotherapy: a Hellenic Co-operative oncology Group study

Med Pediatr Oncol. 1997 Jun;28(6):401-10. doi: 10.1002/(sici)1096-911x(199706)28:6<401::aid-mpo2>3.0.co;2-k.

Abstract

A group of 154 patients with locally advanced head and neck cancer, treated with platinum-based induction chemotherapy, were followed up for 5 years and several pretreatment characteristics were analyzed for possible correlation to a complete response (CR) to chemotherapy, time to progression (TTP) and overall survival (OS). Clinical stage (p = 0.0024) and a history of smoking (p = 0.0125) were selected as important prognostic factors for CR by step wise logistic regression. We also identified response to chemotherapy (p = 0.0120), age (p = 0.0066), clinical stage (p = 0.0363), N stage (p = 0.0028), and tumor grade (p = 0.0101) as significant prognostic variables for TTP. Response to chemotherapy (p < 0.0001) and age (p = 0.0017) were found also significant for OS. These long-term prognostic factors which retain their prognostic significance after several years of follow-up could be helpful in the design of future trials in this patient population.

Publication types

  • Multicenter Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Disease Progression
  • Female
  • Griechenland
  • Head and Neck Neoplasms / drug therapy*
  • Head and Neck Neoplasms / mortality*
  • Head and Neck Neoplasms / pathology
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Platinum Compounds / therapeutic use*
  • Prognosis
  • Remission Induction
  • Risk Factors
  • Survival Analysis
  • Time Factors

Substances

  • Platinum Compounds